SATI.AQSE

Sativa Investments plc
Sativa Group PLC - Update Re-Listing of Stillcanna on CSE
18th September 2020, 07:07
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4228Z
Sativa Group PLC
18 September 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Sativa Group Plc
("Sativa" or the "Company" or the "Group")

Update Regarding Re-Listing of the Common Shares
of Stillcanna Inc. on the Canadian Securities Exchange

18 September 2020

 

Further to the Company's news release dated September 10, 2020, Sativa wishes to provide an update on the status of the re-listing of Stillcanna Inc. (to be renamed Sativa Wellness Group Inc.) ("Stillcanna") common shares on the Canadian Securities Exchange (the "CSE") and the AQSE Growth Market (the "AQSE"). The Company is currently co-ordinating with Stillcanna a date of re-listing with the CSE, and continues to work diligently to fulfil the remaining conditions of re-listing. The Company now expects to resume trading following the satisfaction of various minor procedural conditions, which will occur on or around the end of September on the CSE, with a quotation on the AQSE expected on or around the same time.

 

A new corporate website that will be AQSE Growth Market Rule 71 compliant on admission, has been launched for shareholders and investors to gain further information. Please go online to www.sativawellnessgroup.com. The new trading symbol, (ticker), will be "SWEL" for Sativa Wellness Group Inc. trading on the CSE and AQSE. Additional information regarding Sativa Wellness is available under the Company's SEDAR profile (www.sedar.com).

 

The newly released corporate video, housed on our new Sativa Wellness Group YouTube channel, explains how we have created a fully integrated European seed to consumer offering. By having the stewardship of the product through the entire supply chain it will allow us to not only deliver consistent quality to our consumers, but also CBD you can trust from the ability to be fully compliant with all European industry regulations such as the FSA Novel Foods Accreditation.

The directors of the Company accept responsibility for the contents of this announcement.

Enquiries:

Henry Lees-Buckley 

Chief Executive Officer

Sativa Group Plc

+44 (0) 20 7971 1255

enquiries@sativagroup.co.uk

www.sativagroup.co.uk

 

Joseph Colliver

Chief Financial Officer

Sativa Group Plc

+44 (0) 20 7971 1255

enquiries@sativagroup.co.uk

www.sativagroup.co.uk

 

AQSE Growth Market Corporate Adviser

Corporate Finance 

Guy Miller/Allie Feuerlein

Peterhouse Capital Limited

+44 (0) 20 7220 9795


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFIFIDAEITLII ]]>
TwitterFacebookLinkedIn